| 000 | 01651 a2200481 4500 | ||
|---|---|---|---|
| 005 | 20250517010815.0 | ||
| 264 | 0 | _c20160406 | |
| 008 | 201604s 0 0 eng d | ||
| 022 | _a1532-866X | ||
| 024 | 7 |
_a10.1016/j.semarthrit.2014.11.003 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aAbasolo, Lydia | |
| 245 | 0 | 0 |
_aSafety of disease-modifying antirheumatic drugs and biologic agents for rheumatoid arthritis patients in real-life conditions. _h[electronic resource] |
| 260 |
_bSeminars in arthritis and rheumatism _cApr 2015 |
||
| 300 |
_a506-513 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Observational Study | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntirheumatic Agents _xadverse effects |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 |
_aBiological Products _xadverse effects |
| 650 | 0 | 4 | _aDatabases, Factual |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMethotrexate _xadverse effects |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aLeon, Leticia | |
| 700 | 1 | _aRodriguez-Rodriguez, Luis | |
| 700 | 1 | _aTobias, Aurelio | |
| 700 | 1 | _aRosales, Zulema | |
| 700 | 1 | _aMaria Leal, Jose | |
| 700 | 1 | _aCastaño, Victor | |
| 700 | 1 | _aVadillo, Cristina | |
| 700 | 1 | _aMacarron, Pilar | |
| 700 | 1 | _aFontsere, Oscar | |
| 700 | 1 | _aJover, Juan Angel | |
| 773 | 0 |
_tSeminars in arthritis and rheumatism _gvol. 44 _gno. 5 _gp. 506-513 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.semarthrit.2014.11.003 _zAvailable from publisher's website |
| 999 |
_c24481059 _d24481059 |
||